Recombinant multi-species NOD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NOD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family of proteins. The encoded protein plays a role in innate immunity by acting as a pattern-recognition receptor (PRR) that binds bacterial peptidoglycans and initiates inflammation. This protein has also been implicated in the immune response to viral and parasitic infection. Major structural features of this protein include an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and 10 tandem leucine-rich repeats (LRRs) in its C terminus. The CARD is involved in apoptotic signaling, LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. Mutations in this gene are associated with asthma, inflammatory bowel disease, Behcet disease and sarcoidosis in human patients. [provided by RefSeq, Aug 2017]
The Alternative Names of target: C230079P11,CARD4,CLR7.1,Card4,Caspase recruitment domain-containing protein 4,F830007N14Rik,NLRC1,NOD1,Nlrc1,Nod1,Nucleotide-binding oligomerization domain-containing protein 1,RGD1562269,hNod1,mNod1
Go
to NOD1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T21038-Ag-1/ GM-Tg-hg-T21038-Ag-2 | Human NOD1 protein | Human |
| GM-Tg-rg-T21038-Ag-1/ GM-Tg-rg-T21038-Ag-2 | Rat NOD1 protein | Rat |
| GM-Tg-mg-T21038-Ag-1/ GM-Tg-mg-T21038-Ag-2 | Mouse NOD1 protein | Mouse |
| GM-Tg-cynog-T21038-Ag-1/ GM-Tg-cynog-T21038-Ag-2 | Cynomolgus/Rhesus macaque NOD1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T21038-Ag-1/ GM-Tg-felg-T21038-Ag-2 | Feline NOD1 protein | Feline |
| GM-Tg-cang-T21038-Ag-1/ GM-Tg-cang-T21038-Ag-2 | Canine NOD1 protein | Canine |
| GM-Tg-bovg-T21038-Ag-1/ GM-Tg-bovg-T21038-Ag-2 | Bovine NOD1 protein | Bovine |
| GM-Tg-equg-T21038-Ag-1/ GM-Tg-equg-T21038-Ag-2 | Equine NOD1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T21038-Ag-1/ GM-Tg-hg-T21038-Ag-2;
GM-Tg-rg-T21038-Ag-1/ GM-Tg-rg-T21038-Ag-2;
GM-Tg-mg-T21038-Ag-1/ GM-Tg-mg-T21038-Ag-2; GM-Tg-cynog-T21038-Ag-1/ GM-Tg-cynog-T21038-Ag-2; GM-Tg-felg-T21038-Ag-1/ GM-Tg-felg-T21038-Ag-2; GM-Tg-cang-T21038-Ag-1/ GM-Tg-cang-T21038-Ag-2; GM-Tg-bovg-T21038-Ag-1/ GM-Tg-bovg-T21038-Ag-2; GM-Tg-equg-T21038-Ag-1/ GM-Tg-equg-T21038-Ag-2 |
| Products Name | NOD1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NOD1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NOD1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.